microsomes and reduced nicotinamide adenine dinucleotide phosphate
(NADPH) were obtained from Fisher Scientific SL. This assay gives
information on the metabolic stability of early drug discovery compounds
based on liver microsomes. Microsome stability was tested by incubating
10 μM of test compounds (
hepatic microsomes (pooled human liver microsomes and pooled mouse
(CD-1) liver microsomes) in 0.1 M potassium phosphate buffer (pH 7.4)
with MgCl2 5 mM. The reaction was initiated by adding NADPH
(1 mM final concentration). Aliquots of 150 μL were collected
at defined time points (0, 5, 15, 30, 45, and 60 min) and added to
cold acetonitrile (150 μL) containing an internal standard (5
μg/mL warfarin) to stop the reaction and precipitate the protein.
After stopping the reaction, the samples were centrifuged at 4 °C
for 15 min and the loss of parent compounds was analyzed by HPLC–MS
using single ion mode (SIM) detection. Data were log transformed and
represented as half-life. All experiments were conducted by duplicate.